Airway stenting for malignant aerodigestive fistulae: A critical review of the literature and treatment recommendations
The development of trachea- or broncho-esophageal fistulae is a devastating thoracic malignancy complication leading to increased morbidity and mortality due to pneumonia, sepsis, and malnutrition. Due to this high morbidity and mortality, attempts to close or cover the fistula are often undertaken. Multiple modalities have been evaluated and reported to treat malignant aerodigestive fistulae (MAF), although no single approach has become the standard of care. The American College of Chest Physicians recommends palliative stenting for MAF, but this approach may not be effective depending on size, configuration, and position of the fistula. This manuscript will critically evaluate the role of single airway stenting or double airway and esophageal stenting in MAF palliation. We will recommend an approach to consider with regard to the management of these fistulae.
aSection of Interventional Pulmonology and Thoracic Oncology, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
bDepartment of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Address reprint requests to Anthony R. Lanfranco, MD, Section of Interventional Pulmonology and Thoracic Oncology, Division of Pulmonary, Allergy, and Critical Care Medicine, 8th Floor Maloney Building, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104-4283
The authors report no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.